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Abstract
Background: The objective of this study was to determine complete blood count (CBC)
abnormalities in Libreville blood donors to advocate for hemoglobin pre-donation
implementation and to take into account CBC results in blood donation qualification.
Methods: This retrospective study was conducted with 4,573 blood donors in March
2016 and from January to April 2017. CBC was performed using SysmexXP-300TM
hematology analyzer (SYSMEX Corporation, Kobe, Japan).
Results: Blood donors were predominantly males (83.7%) with an age ranging from
18 to 59 yrs. The abnormalities of leukocyte, platelet, and erythrocyte counts were
determined in blood donors. Leukopenia and thrombocytopenia were significantly
more common in men than women (29.02% vs 24.4%, p = 0.011 and 16.2% vs 7.5%, p <
0.001). Only 1.0% of women and 0.84% of men had leukocytosis, and 0.7% of women
and 0.2% of men had thrombocytosis. Anemia was significantly more common in
women compared to men (69.4% vs 45.0%, p < 0.001). Normocytic normochromic and
normocytic hypochromic anemia were most common among Libreville blood donors
with 39.4% and 23.6%; followed by microcytic normochromic (18.7%) and microcytic
hypochromic (13.2%) anemia. Normocytic normochromic and normocytic hypochromic
anemia were significantly more common in men than in women, whereas microcytic
normochromic anemia was more prevalent among women compared to men (34.6%
vs 13.9%, p < 0.001).
Conclusions: The results of this study clearly show the need to perform a pre-donation
hemoglobin test in blood donors and to take into account their hemogram in the blood
donation selection process at the Libreville National Blood Transfusion Center.
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1. Introduction
Blood transfusion is a therapeutic procedure that saves lives by providing patients
with the blood products they need according to their disease. It remains an essential
component in the treatment of hemoglobinopathies, particularly sickle cell disease [1].
The stages of the transfusion chain that begin with the reception of the blood donor and
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end with the transfusion of the compatible blood product to the recipient are essential
to observe in order to guarantee the quality of the transfused products [2]. One of these
most important steps is the blood donation qualification by the transfusion physician
during the pre-donation interview [3].
The qualification for blood donation is done by checking the donor for certain clinical
and hematological parameters to evaluate their ability to donate. The measurement
of hematological parameters in transfusion medicine is important in that it allows the
detection of quantitative abnormalities of the cellular elements of the blood. However,
according to the report of the transfusion research group in French-speaking Africa, the
measurement of these parameters is very little done in sub-Saharan Africa during the
biological testing of a blood donation [4]. The measurement of hemoglobin is the only
pre-donation screening preventing the occurrence of donation-induced anemia. It also
avoids bleeding in an already anemic donor.
Various factors are known to cause changes in the rate of red blood cells in an
individual, such as sex, age, pregnancy, altitude, and ethnicity [5]. The measurement
of hemoglobin and the assessment of anemia should be corrected taking into account
ethnicity. Indeed, it has been shown that the average values of hemoglobin levels of
African-American subjects are lower than those of American subjects of other ethnic
origins [6]. A recent report has shown lower hemoglobin values in Africans compared to
Caucasians [7]. Most blood centers perform hemoglobin testing during the pre-donation
interview using the copper sulfate method in relation to its very low cost. However,
previous studies have shown that anemia was observed in 42% of blood donors in
Africa [8, 9]. While progress has been observed at the National Blood Transfusion Center
in Libreville in terms of reducing the post-transfusion risk of transfusion-transmissible
infections, measures taken to improve the blood donation qualification during the
medical interview need to be improved [10–12]. Indeed, the hematological parameters
of the donor are verified post-donation and are only clinical information for the donor.
The measurement of the hemoglobin level that represents the hematological parameter
of eligibility for donation is not yet done during the pre-donation medical interview. This
study was designed to evaluate the erythrocyte, leukocyte, and platelet counts of first-
time blood donors of Libreville to determine the prevalence and characteristics of their
abnormalities.
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2. Methods
2.1. Blood donors
A cross-sectional analysis of blood donor data collected first in March 2016 and second
between January and April 2017 was conducted at the National Blood Transfusion
Center (NBTC). All apparently healthy voluntary non-remunerated donors (VNRD) and
family/replacement donors (FRD) were selected after responding to a range of questions
including medical history. Individuals aged 18 to 59 yrs and weighing ≥ 50 kg were
eligible for blood donations. All candidate donors responded to questions aiming at the
exclusion of transfusion recipients, individuals who had jaundice or signs of hepatitis,
pregnant women, and persons with unsafe sexual behavior during the six months prior
to blood donation. Blood donors signed a written informed consent forms prior to
blood collection. Venous blood was collected in the blood bags following standard
procedures.
2.2. Hemogram profile determination
The complete blood count (CBC) was performed using an automated Hematology
Analyzer Sysmex XP-300TM (SYSMEX Corporation, Kobe, Japan) according to the man-
ufacturer’s instructions.
The instrument automatically counts and gives a printout result of absolute numbers
of erythrocytes (RBC) (1012/L), hemoglobin (g/dL), hematocrit (%), MCV (fl), MCHC (g/dL),
leukocytes (WBC) (109/L), and platelets (109/L).
2.3. Statistical analysis
Statistical analyseswere performedwith the software EpiInfo version 6 and SPSS version
20; p ≤ 0.05 was considered significant.
3. Results
3.1. Demographic characteristics of the study population
This study involved 4,573 blood donors at the NBTC in Libreville. Blood donors were
predominantly males (83.7%). The male/female sex ratio was 5/1. The age of blood
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donors ranged from 18 to 49 yrs for women and 18 to 59 yrs for men. The age groups
20–29 and 30–39 yrs were the most represented in both women (52.2% and 34.9%)
and men (48.4% and 35.8%) (Table 1).
Table 1: Repartition of blood donors by age groups.
Female Male
Age groups Number Percentage Number Percentage
< 20 yrs 12 1.6 37 1.0
20–29 yrs 389 52.2 1,851 48.4
30–39 yrs 260 34.9 1,369 35.8
40–49 yrs 84 11.3 504 13.2
50–59 yrs – – 67 1.8
Total 745 3,828
3.2. Mean values of the blood count in blood donors
The mean values of hematological parameters such as RBC, Hb, HCT, MCV, MCHC,
WBC, and PLT are presented in Table 2. The mean values of erythrocyte parameters
(RBC, Hb, HCT, and MCV) were significantly higher in men compared to women (Table
2). Only MCHC was higher in women compared to men (p = 0.009). In contrast, the
mean value of PLT was significantly higher in women compared to men (p < 0.001),
while the WBC average was similar for both sexes (p = 0.068).
3.3. Abnormalities of blood donors’ blood count by gender
The abnormalities of the hemogram of blood donors have been observed mainly in
the erythrocytes. In fact, 69.4% and 84.4% of women had lower Hb and HCT levels,
respectively, while 32.3% and 24.4% of them had MCV and MCHC values lower than
the lower limits, respectively. Leukocyte and platelet counts showed little abnormality
with 74.4% and 91.8% of female blood donors withWBC and PLT levels between baseline
values (Table 3).
In male blood donors, the abnormalities of the blood count mainly concerned ery-
throcytes with 45%, 52.2% and 28.6% with Hb, HCT, and MCHC levels below the lower
limit and only 0.2%, 0.5%, and 1.7% of these had Hb, HCT, and MCHC levels above the
upper limit (Table 3). With respect to leukocytes and platelets, 29.02% and 16.2% of
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Table 2: Comparison of mean values of complete blood count (CBC) in female and male blood donors.
Hematological parameters Female Male
Mean ± SD Mean ± SD P-value*
RBC x 1012/L 4.049 ± 0.531 4.878 ± 7.425 < 0.001
Hb (g/dL) 10.802 ± 1.478 13.092 ± 1.538 < 0.001
HCT (%) 32.860 ± 4.433 39.813 ± 4.538 < 0.001
MCV (ƒL) 81.294 ± 8.261 84.586 ± 6.953 < 0.001
MCHC (%) 32.977 ± 2.804 32.975 ± 2.708 0.009
WBC x 109/L 5.035 ± 1.911 4.915 ± 1.512 0.068
PLT x 109/L 239.168 ± 68.931 203.015 ± 59.690 < 0.001
RBC: Red blood cell; Hb: Hemoglobin; HCT: Hematocrit; MCV: Mean corpuscular volume; MCHC:
Mean corpuscular hemoglobin concentration; WBC: White blood cell; PLT: Platelets.
*Mann–Whitney test
Table 3: Distribution of erythrocyte, leukocyte, and platelet parameters of female versus male blood donors




Reference values Number of female vs
male donors whose
value is below the
lower limit
Number of female vs
male donors whose







Numbers % Numbers % Numbers %
RBC (x 1012/L) F: 4 < RBC < 5.3
M: 4.2 < RBC < 5.7
359/707 48.2/18.5 359/2859 48.2/74.7 27/262 3.6/6.8
Hb (g/dL) F : 12 < Hb < 16
M : 13 < Hb < 18
517/1724 69.4/45.0 224/2098 30.0/54.8 4/6 0.6/0.2
HCT (%) F : 37 < HCT < 46
M : 40 < HCT < 52
629/1998 84.4/52.2 112/1812 15.0/47.3 4/18 0.5/0.5
MCV (fL) 80 ≤ MCV ≤ 100 241/494 32.3/12.9 498/3302 66.8/86.3 6/32 0.8/0.8
MCHC (%) 32 ≤ MCHC ≤ 36 182/1094 24.4/28.6 527/2669 70.7/69.7 36/65 4.8/1.7
WBC (x 109/L) 4 < WBC < 10 183/1111 24.6/29.02 554/2685 74.4/70.14 8/32 1.0/0.84
PLT (x 109/L) 150 < PLT < 450 56/620 7.5/16.2 684/3199 91.8/83.6 5/9 0.7/0.2
RBC: Red blood cell; Hb: Hemoglobin; HCT: Hematocrit; MCV: Mean corpuscular volume; MCHC: Mean
corpuscular hemoglobin concentration; WBC: White blood cell; PLT: Platelets.
men had WBC and PLT counts below the lower limit and only 0.84% and 0.2% of these
showed WBC and PLT rates above the upper limit (Table 3).
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3.4. Comparison of blood count abnormalities in blood donors by
gender
The three hematological parameters that have been taken into account are hemoglobin
level (anemia), white blood cells (leukopenia and leukocytosis), and platelets (throm-
bocytopenia and thrombocytosis). The results show that women were significantly
more frequently anemic than men (69.4% vs 45%, p < 0.001), while leukopenia and
thrombocytopenia were significantly more common in men than women (29.02% vs
24.4%, p = 0.011 and 16.2% vs 7.5%, p < 0.001) (Table 4). Only 1.0% of women and 0.84%
of men had leukocytosis, and 0.7% of women and 0.2% of men had thrombocytosis
(Table 4).
Table 4: Comparison of erythrocytes, leucocytes, and platelets abnormalities in blood donors by gender.
Female Male
Hematological parameters Number Percentage Number Percentage P-value
Hb (Female: Hb < 12 ; Male: Hb < 13) 517 69.4 1,742 45.0 < 0.001
WBC
Leukopenia (WBC < 4 x 109/L) 182 24.4 1,111 29.02 0.011
Leukocytosis (WBC > 10 x 109/L) 8 1.0 32 0.84 0.778
PLT
Thrombocytopenia (PLT < 150 x 109/L) 56 7.5 620 16.2 < 0.001
Thrombocytosis (PLT < 450 x 109/L) 5 0.7 9 0.2 0.073
Hb: Hemoglobin; WBC: White blood cell; PLT: Platelets.
3.5. Characterization of different levels and types of anemia in
Libreville blood donors
Anemia was significantly more frequent in women compared to men in the age groups
< 20 yrs and 20–29 yrs (2.0% vs 1.1%, p = 0.039 and 52.6% vs 46.7%, p = 0.002) (Table
5). In contrast, among blood donors aged 40 to 49 years, anemia was more prevalent
in men compared to women (16.1% vs 11.2%, p < 0.001).
With regard to the degree of anemia, slight anemia predominated in both women
(63.2%) and men (84.8%). Severe or moderate anemia was observed in 4.3% and
32.5% of women and 1.3% and 13.9% of men, respectively. They were significantly
more frequent in women compared to men (p < 0.001 and p < 0.001) (Table 5).
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Table 5: Comparison of anemia level among blood donors by gender and age.
Female with anemia Male with anemia
Parameters Number % Parameters Number % P-value
Age groups
< 20 yrs 10 2 < 20yrs 19 1.1 0.039
20–29 yrs 272 52.6 20–29yrs 802 46.5 0.002
30–39 yrs 177 34.2 30–39yrs 586 34 0.91
40–49 yrs 58 11.2 40–49yrs 278 16.1 < 0.001
50–59 yrs – – 50–59yrs 39 2.3
Anemia level
Severe (Hb < 8) 22 4.3 Severe (Hb < 9) 22 1.3 < 0.001
Mild (8 < Hb < 10) 168 32.5 Mild (9 < Hb < 11) 240 13.9 < 0.001
Slight (10 < Hb < 12) 327 63.2 Slight (11 < Hb < 13) 1,462 84.8 < 0.001
Normocytic normochromic and normocytic hypochromic anemia were most common
among Libreville blood donors with 39.4% and 23.6%, respectively. They were followed
by microcytic normochromic (18.7%) and microcytic hypochromic (13.2%) anemia. All
types of hyperchromic anemia were found in 3.4% (77/2241) of blood donors. The
different types of anemia were not associated with age of the blood donors (Table
6). Microcytic normochromic anemia was significantly more frequent in female blood
donors compared to male blood donors (p < 0.001). While normocytic hypochromic or
normochromic anemia were more prevalent in men than in women (p < 0.001 and p <
0.001) (Table 6).
4. Discussion
This study was conducted with the aim of improving the qualification criteria for blood
donation at the NBTC located in Libreville by including the results of the CBC in the
transfusion process. The measurement of hematological parameters in blood donors
by CBC allows the diagnosis of certain existing blood abnormalities in the donor to
establish a first barrier against transmitted-transfusion infections. In Libreville blood
donors, we observed that red cell parameters (RBC, Hb, HCT, and MCV) were higher in
men compared to women. The mean of WBC was similar for both sexes. In contrast, the
mean of PLT was higher among women than men which is in agreement with previous
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Table 6: Comparison of anemia type among blood donors by gender and age.
Type of anemia
MAHA MAHyA MANA MIHA MIHyA MINA NHA NHyA NNA
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Gender
Female 0 (0.0) 6 (1.2) 0 (0.0) 5 (1.0) 57 (11.0) 179 (34.6) 7 (1.4) 93 (18.0) 170 (32.9)
Male 1 (0.1) 28 (1.6) 3 (0.2) 15 (0.9) 239 (13.9) 240 (13.9) 49 (2.8) 435 (25.2) 714 (41.4)
P-value NC NS NC NS NS < 0.001 NS < 0.001 < 0.001
Age groups
< 20 yrs 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.4) 3 (10.3) 8 (27.6) 1 (3.4) 8 (27.6) 8 (27.6)
20–29 yrs 0 (0.0) 17 (1.6) 1 (0.1) 12 (1.1) 147 (13.7) 211 (19.6) 28 (2.6) 231 (21.5) 427 (39.8)
30–39 yrs 0 (0.0) 9 (1.2) 1 (0.1) 4 (0.5) 87 (11.4) 148 (19.4) 17 (2.2) 188 (24.6) 309 (40.5)
40–49 yrs 1 (0.3) 6 (1.8) 1 (0.3) 3 (0.9) 56 (16.7) 47 (14.0) 9 (2.7) 87 (25.9) 126 (37.5)
50–59 yrs 0 (0.0) 2 (5.1) 0 (0.0) 0 (0.0) 3 (7.7) 5 (12.8) 1 (2.6) 14 (35.9) 14 (35.9)
P-value NC NS NC NS NS NS NS NS NS
MAHA: Macrocytic hyperchromic anemia; MAHyA: Macrocytic hypochromic anemia; MANA: Macrocytic
normochromic anemia; MIHA: Microcytic hyperchromic anemia; MIHyA: Microcytic hypochromic anemia;
MINA: Microcytic normochromic anemia; NHA: Normocytic hyperchromic anemia; NHyA: Normocytic
hypochromic anemia; NNA: Normocytic normochromic anemia.
studies [13–15]. The mean values of red cell parameters vary with age and sex [16].
Indeed, values are higher in men compared to women, which is in agreement with the
results of a recent report [7]. On the other hand, no difference between women and men
was found for the leukocyte count as previously reported [17, 18]. Leukocyte, platelet,
and erythrocyte abnormalities of blood donors were assessed. CBC of blood donors
showed that 70.8% of these showed no leucocyte abnormality. However, leukopenia
was the most frequently observed WBC abnormality with a prevalence of 28.3%. Two
previous studies in Nigeria and Cameroon reported the prevalence of leukopenia of
12.5% and 14.96% in blood donors [19, 20]. Leukopenia was significantly more prevalent
in men than in women.
Leukocytosis was present in only 0.9% of Libreville blood donors, while it was the
most observed leukocyte abnormality in Morocco with 5.27% [18].
With respect to platelet count, 84.9% of blood donors had no platelet count abnor-
malities. Thrombocytopenia (14.8%) was the most observed abnormality compared to
thrombocytosis (0.3%). Thrombocytopenia was significantly higher in men compared to
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women. Thrombocytopenia may be central or peripheral due to destruction or excessive
consumption of platelets. In this study, thrombocytosis was higher in women than in
men as reported previously [21, 22]. But the difference observed was not significant.
The observed thrombocytosis may be due in part to infections or iron deficiency [23].
With regard to the erythrocyte, anemia was found in 49% of blood donors. The
prevalence of anemia found in our study is significantly higher than those of 36.5%
and 28% observed, respectively, in Congo and Cameroon [20, 24]. Lower anemia
prevalences of 8.6% has been reported in North Africa, particularly in Tunisia [25]. The
most anemic age group was 20 to 29 yrs, with rates of 52.6% and 46.5%, respectively,
for women and men. In Morocco, anemia rates of 43.5% and 42.5% were reported in the
age group 30–39 yrs for both women and men [18]. In Congo, however, the prevalence
of anemia was higher in the 40–49 age group, with 42.7% in both sexes [24]. The high
prevalence of anemia found in this study could be explained by the high prevalence of
hemoglobinopathies in Gabon such as alpha and beta thalassemias, sickle cell anemia,
and Glucose-6-Phosphate Deshydrogenase deficiency [26–28].
In this study, we found that women (69.4%) were more frequently anemic than men
(45.0%). Many studies in Africa have also reported variable prevalence of anemia among
women ranging from 49% in Tanzania to 16.9% in Tunisia [25, 29]. Slight anemia was
found in 84.8% of men and 63.2% of women. These results suggest that anemia,
according to thresholds established by the WHO, is probably well tolerated by blood
donors in Gabon as few adverse events following blood donation in Libreville have been
reported among blood donors. Therefore, it could be more appropriate to establish
threshold hemoglobin values specific to the Gabonese population in particular and to
populations of color in sub-Saharan Africa in general to define anemia.
In this study, the most common anemias in Libreville blood donors were normocytic
normochromic (39.4%) and normocytic hypochromic (23.6%). The highest prevalence
of normocytic normochromic anemia observed in Libreville blood donors is consistent
with the prevalence of 46.74% reported previously in Ghana [30]. The distribution of
these two types of anemia was not identical in both sexes. Normocytic normochromic
and normocytic hypochromic anemia were significantly more frequent in men than in
women.
In contrast of the studies of Bakrim et al. in Morocco and Nzengu-Lukusa in Demo-
cratic Republic of Congo (DRC) [18, 24], who found high prevalence of microcytic anemia
in blood donors, we observed microcytic normocytic and microcytic hypochromic ane-
mia, respectively, in 18.7% and 13.2% of blood donors. Microcytic normochromic anemia
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was significantly more frequent in women (34.6%) than men (13.9%). In this study, we did
not perform iron assessment. However, the prevalence of 13.2% microcytic hypochromic
anemia observed in Libreville blood donors may be associated with iron deficiency.
Indeed, previous studies in Burkina Faso, Tunisia, and India have shown the association
between microcytosis and Iron deficiency anemia [25, 31, 32].
5. Conclusion
The aim of this study was to provide reliable data to advocate for pre-donation
hemoglobin measurement in Libreville blood donors and to take into account CBC
results in blood donation qualification. It appears that blood count abnormalities
frequently encountered in blood donors were leucopenia, thrombocytopenia, and
normocytic normochromic anemia. Since anemia is present in about half of the blood
donor population, a specific hemoglobin threshold in Gabon from which a donation
could be authorized should be defined.
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